Back to Search Start Over

Vaccine priming of rare HIV broadly neutralizing antibody precursors in nonhuman primates.

Authors :
Steichen JM
Phung I
Salcedo E
Ozorowski G
Willis JR
Baboo S
Liguori A
Cottrell CA
Torres JL
Madden PJ
Ma KM
Sutton HJ
Lee JH
Kalyuzhniy O
Allen JD
Rodriguez OL
Adachi Y
Mullen TM
Georgeson E
Kubitz M
Burns A
Barman S
Mopuri R
Metz A
Altheide TK
Diedrich JK
Saha S
Shields K
Schultze SE
Smith ML
Schiffner T
Burton DR
Watson CT
Bosinger SE
Crispin M
Yates JR 3rd
Paulson JC
Ward AB
Sok D
Crotty S
Schief WR
Source :
Science (New York, N.Y.) [Science] 2024 May 17; Vol. 384 (6697), pp. eadj8321. Date of Electronic Publication: 2024 May 17.
Publication Year :
2024

Abstract

Germline-targeting immunogens hold promise for initiating the induction of broadly neutralizing antibodies (bnAbs) to HIV and other pathogens. However, antibody-antigen recognition is typically dominated by heavy chain complementarity determining region 3 (HCDR3) interactions, and vaccine priming of HCDR3-dominant bnAbs by germline-targeting immunogens has not been demonstrated in humans or outbred animals. In this work, immunization with N332-GT5, an HIV envelope trimer designed to target precursors of the HCDR3-dominant bnAb BG18, primed bnAb-precursor B cells in eight of eight rhesus macaques to substantial frequencies and with diverse lineages in germinal center and memory B cells. We confirmed bnAb-mimicking, HCDR3-dominant, trimer-binding interactions with cryo-electron microscopy. Our results demonstrate proof of principle for HCDR3-dominant bnAb-precursor priming in outbred animals and suggest that N332-GT5 holds promise for the induction of similar responses in humans.

Details

Language :
English
ISSN :
1095-9203
Volume :
384
Issue :
6697
Database :
MEDLINE
Journal :
Science (New York, N.Y.)
Publication Type :
Academic Journal
Accession number :
38753769
Full Text :
https://doi.org/10.1126/science.adj8321